MEGAN WERBEL: Open Payments
NPI 1104563337 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 16 payments from 9 companies in 2025. Trend: 2023 $218 · 2024 $480 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $105 |
| Stryker Corporation | 2 | $89 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $24 |
| Integra LifeSciences Corporation | 1 | $21 |
| AERIN MEDICAL INC. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: DUPIXENT, AUDION ET DILATION SYSTEM, NUCALA, KEYTRUDA, TEZSPIRE, Integra, VIVAER STYLUS, XHANCE.
Industry payments across FL — which companies pay providers there.
